Materials and methods for colorectal cancer screening,...

Details Materials and methods for colorectal cancer screening,... Materials and methods for colorectal cancer screening,...

2004-08-06

2011-10-04

Kapushoc, Stephen (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091200, C435S007100, C536S023100

Reexamination Certificate

active

08029984

ABSTRACT:
The invention provides materials and methods for colorectal cancer screening, diagnosis, and therapy.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5093246 (1992-03-01), Cech et al.
patent: 5116742 (1992-05-01), Cech et al.
patent: 5225337 (1993-07-01), Robertson et al.
patent: 5254678 (1993-10-01), Haseloff et al.
patent: 5750652 (1998-05-01), Artavanis-Tsakonas et al.
patent: 5780300 (1998-07-01), Artavanis-Tsakonas et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 6004924 (1999-12-01), Ish-Horowicz et al.
patent: 6083904 (2000-07-01), Artavanis-Tsakonas
patent: 6121045 (2000-09-01), McCarthy et al.
patent: 6262025 (2001-07-01), Ish-Horowicz et al.
patent: 6291210 (2001-09-01), Sakano et al.
patent: 6380362 (2002-04-01), Watson et al.
patent: 6433138 (2002-08-01), Zimrin et al.
patent: 6436650 (2002-08-01), Artavanis-Tsakonas et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2003/0087807 (2003-05-01), Greenspan
patent: 2003/0224516 (2003-12-01), Dobie
patent: 2005/0271636 (2005-12-01), Oliver et al.
patent: 2006/0088532 (2006-04-01), Alitalo et al.
patent: 2007/0110744 (2007-05-01), Alitalo et al.
patent: WO 96/34096 (1906-10-01), None
patent: WO 90/07641 (1990-07-01), None
patent: WO 93/23569 (1993-11-01), None
patent: WO 94/02602 (1994-02-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 96/34096 (1996-10-01), None
patent: WO-00/06726 (2000-02-01), None
patent: WO-02/24221 (2000-03-01), None
patent: WO 00/32765 (2000-06-01), None
patent: WO-01/12664 (2001-02-01), None
patent: WO 03/027285 (2003-04-01), None
patent: WO-03/027285 (2003-04-01), None
patent: WO-03/047532 (2003-06-01), None
patent: WO-03/080640 (2003-10-01), None
patent: WO-2005/026362 (2005-03-01), None
Cheung V.G. et al. Nature Genetics (Mar. 2003) vol. 33, p. 422-425.
Hoshikawa Y. et al. Physiol Genomcs (2003) vol. 12, p. 209-219.
Chen G. et al. Molecular and Cellular Proteomics Apr. 2002;1(4):304-13.
Parr C. Int J Oncol. Aug. 2003;23(2):533-9.
Rockman S.P. et al. Journal of Biological Chemistry (2001) vol. 276, No. 48, Issue of Nov. 30, pp. 45113-45119.
Kinzler et al., “Lessons from Hereditary Colorectal Cancer,”Cell, 87, 159-170 (1996).
Lohela et al., “Lymphangiogenic Growth Factors, Receptors and Therapies,”Thrombosis and Haemostasis, 90(2):167-184 (2003).
Maillard et al., “Notch and Cancer: Best to Avoid the Ups and Downs,”Cancer Cell, 203-205 (2003).
Petrova et al., “Effects of Lymphatic Transcription Factor Prox-1 on Cell Cycle Progression,”J. Submicro. Cyt. Path., 32(3):406 (2000).
Wigle et al., “An Essential Role forProx1in the Induction of the Lymphatic Endothelial Cell Phenotype,”EMBO J., 21(7):1505-1513 (2002).
Xia et al., “siRNA-mediated Gene Silencing in Vitro and in Vivo,”Nat. Biotech., 20(10):1006-1010 (2002).
International Search Report for International Application No. PCT/EP2004/008819, mailed Dec. 29, 2004.
Written Opinion for International Application No. PCT/EP2004/008819, mailed Dec. 29, 2004.
Artavanis-Tsakonas, Notch Signaling: Cell fate control and signal integration in development.Science, vol. 284, pp. 770-776 (1999).
Bach et al., Stem cells: The intestinal stem cell as paradigm.Carcinogenesis, vol. 21, pp. 469-476 (2000).
Bange et al., Cancer progression and tumor cell motility are associated with the FGFR4 Arg388 allele.Cancer Res., vol. 62, pp. 840-847 (2002).
Brummelkamp et al., A system for stable expression of short interfering RNAs in mammalian cells.Science, vol. 296, pp. 550-553 (2002).
Cavallaro et al., N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signaling.Nat. Cell Biol., vol. 3, pp. 650-657 (2001).
Chowrira et al., Extensive phosphorothioate substitution yields highly active and nuclease-resistant hairpin ribosymes.Nucleic Acids Res., vol. 20, pp. 2835-2840 (1992).
Cole et al., Generation of human monoclonal antibodies reactive with cellular antigens.Proc. Natl. Acad. Sci.(USA), vol. 80, pp. 2026-2030 (1983).
Daubendiek et al., Generation of catalytic RNAs by rolling transcription of synthetic DNA nanocircles.Nat. Biotechnol., vol. 15, No. 3, pp. 273-277 1997.
Elbashir et al., RNA interference is mediated by 21- and 22-nucleotide RNAs.Genes Dev., vol. 15, pp. 188-200 2001.
Elbashir et al., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature, vol. 411, pp. 494-498 2001.
Fawell et al., Tat-mediated delivery of heterologous proteins into cells.Proc. Natl. Acad. Sci.(USA), vol. 91, pp. 664-668 (1994).
Ferkol et al., Regulation of the phosphoenolpyruvate carboxykinase/human factor IX gene introduced into the livers of adult rats by receptor-mediated gene transfer.FASEB J., vol. 7, pp. 1081-1091 (1993).
Fingl et al., Chapter 1: General Principles. “The Pharmacological Basis of Therapeutics,” pp. 1 (1975).
Fire et al., Potent and specific genetic interference by double-stranded RNA inCaenorhabditis elegans. Nature, vol. 391, pp. 806-811 (1998).
Fujimori et al., Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1β via two NF-κB elements in rat leptomeningeal cells.J. Biol. Chem., vol. 278, pp. 6018-6026 (2003).
Giles et al., Caught up in a WNT storm: Wnt signaling in cancer.Biochem. Biophys. Acta., vol. 1653, pp. 1-24 2003.
Gupta et al., Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.Nat. Rev. Cancer, vol. 1, pp. 11-21 (2001).
Hong et al., Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.Dev. Dyn., vol. 225, pp. 351-357 (2002).
Hutvagner et al., A microRNA in a multiple-turnover RNAi enzyme complex.Science, vol. 297, pp. 2056-2060 (2002).
Jensen et al., Control of endodermal endocrine development by Hes-1.Nat. Genet., vol. 24, pp. 36-44 (2000).
Jordan et al., Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells.J. Clin. Invest., vol. 104, pp. 1061-1069 (1999).
Joutel et al., Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.Nature, vol, 383, pp. 707-710 (1996).
Kaneda et al., Increased expression of DNA cointroduced with nuclear protein in adult rat liver.Science, vol. 243, pp. 375-378 (1989).
Kato et al., Expression of hepatitis B virus surface antigen in adult rat liver.J. Biol. Chem., vol. 266, pp. 3361-3364 (1991).
Kawasaki et al., Hes1 is a target of microRNA-23 during retinoic-acid-induced neuronal differentiation of NT2 cells.Nature, vol. 423, pp. 838-842 (2003).
Koizumi et al., Design of RNA enzyme distinguishing a single base mutation in RNA.Nucleic Acid Res., vol. 17, pp. 7059-7071 (1989).
Kurreck et al., Design of antisense oligonucleotides stabilized by locked nucleic acids.Nucleic Acids Res., vol. 30, pp. 1911-1918 (2002).
Ladner et al., dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.Cancer Research, vol. 60, pp. 3493-3503 (2000).
Lee et al., Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.Nat. Biotechnol., vol. 20, pp. 500-505 (2002).
Li et al., Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.Nature Genet., vol. 16, pp. 243-251 (1997).
Lima et al., Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity.J. Biol. Chem., vol. 272, pp. 626-638 (1997).
Long et al., Self-cleaving catalytic RNA.FASEB J., vol. 7, pp. 25-30 (1993).
Martinez et al., Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.Cell, vol. 110, pp. 563-574 (2002).
Morrison et al., Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.Proc. Natl. Acad. Sci. (USA), vol. 81, pp. 6851-6855 (1984).
Nagahara et al., Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.Nature M

Affiliated with

Also associated with

Rating

Materials and methods for colorectal cancer screening,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Materials and methods for colorectal cancer screening,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for colorectal cancer screening,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4258223